- Home
- SLXN vs CELZ Comparison
SLXN vs CELZ Comparison
Compare SLXN & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLXN
- CELZ
- Stock Information
- Founded
- SLXN 2008
- CELZ 1998
- Country
- SLXN Israel
- CELZ United States
- Employees
- SLXN N/A
- CELZ N/A
- Industry
- SLXN
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- SLXN
- CELZ Health Care
- Exchange
- SLXN NYSE
- CELZ Nasdaq
- Market Cap
- SLXN 5.2M
- CELZ 4.7M
- IPO Year
- SLXN N/A
- CELZ N/A
- Fundamental
- Price
- SLXN $2.44
- CELZ $2.07
- Analyst Decision
- SLXN Strong Buy
- CELZ
- Analyst Count
- SLXN 1
- CELZ 0
- Target Price
- SLXN $1.00
- CELZ N/A
- AVG Volume (30 Days)
- SLXN 1.3M
- CELZ 23.2K
- Earning Date
- SLXN 11-14-2024
- CELZ 11-08-2024
- Dividend Yield
- SLXN N/A
- CELZ N/A
- EPS Growth
- SLXN N/A
- CELZ N/A
- EPS
- SLXN N/A
- CELZ N/A
- Revenue
- SLXN N/A
- CELZ $11,000.00
- Revenue This Year
- SLXN N/A
- CELZ N/A
- Revenue Next Year
- SLXN N/A
- CELZ N/A
- P/E Ratio
- SLXN N/A
- CELZ N/A
- Revenue Growth
- SLXN N/A
- CELZ N/A
- 52 Week Low
- SLXN $0.21
- CELZ $1.96
- 52 Week High
- SLXN $13.56
- CELZ $10.28
- Technical
- Relative Strength Index (RSI)
- SLXN N/A
- CELZ 32.53
- Support Level
- SLXN N/A
- CELZ $1.96
- Resistance Level
- SLXN N/A
- CELZ $2.50
- Average True Range (ATR)
- SLXN 0.00
- CELZ 0.21
- MACD
- SLXN 0.00
- CELZ -0.00
- Stochastic Oscillator
- SLXN 0.00
- CELZ 17.23
About SLXN BIOMOTION SCIENCES
Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.